---
title: "DexCom Inc. Stock Underperforms Friday When Compared To Competitors"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/273560118.md"
description: "DexCom Inc. (DXCM) shares fell 1.43% to $72.86 on Friday, ending a four-day winning streak, while the S&P 500 rose 0.03% and the Dow Jones fell 0.58%. The stock is 21.87% below its 52-week high of $93.25. Competitors Abbott Laboratories and Insulet Corp. also saw declines of 1.10% and 3.00%, respectively. Trading volume was 5.2 million, below the 50-day average of 5.5 million."
datetime: "2026-01-23T21:58:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/273560118.md)
  - [en](https://longbridge.com/en/news/273560118.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/273560118.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/273560118.md) | [繁體中文](https://longbridge.com/zh-HK/news/273560118.md)


# DexCom Inc. Stock Underperforms Friday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of DexCom Inc. (DXCM) shed 1.43% to $72.86 Friday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.03% to 6,915.61 and the Dow Jones Industrial Average falling 0.58% to 49,098.71. The stock's fall snapped a four-day winning streak. DexCom Inc. closed 21.87% short of its 52-week high of $93.25, which the company achieved on February 18th. The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Abbott Laboratories (ABT) fell 1.10% to $107.42 and Insulet Corp. (PODD) fell 3.00% to $271.60. Trading volume (5.2 M) remained 289,989 below its 50-day average volume of 5.5 M. Data source: Dow Jones Market Data, FactSet. Data compiled January 23, 2026. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 01-23-26 1658ET

### Related Stocks

- [ALPS Medical Breakthroughs ETF (SBIO.US)](https://longbridge.com/en/quote/SBIO.US.md)
- [DexCom, Inc. (DXCM.US)](https://longbridge.com/en/quote/DXCM.US.md)
- [State Street®HlthCrSelSectSPDR®ETF (XLV.US)](https://longbridge.com/en/quote/XLV.US.md)
- [SPDR® S&P Health Care Equipment ETF (XHE.US)](https://longbridge.com/en/quote/XHE.US.md)
- [Vanguard Health Care ETF (VHT.US)](https://longbridge.com/en/quote/VHT.US.md)
- [iShares US Medical Devices ETF (IHI.US)](https://longbridge.com/en/quote/IHI.US.md)

## Related News & Research

- [Is DexCom Stock Underperforming the Nasdaq?](https://longbridge.com/en/news/277946249.md)
- [BUZZ-MAIA Biotechnology plunges after $30 million share sale](https://longbridge.com/en/news/277605454.md)
- [Geoffrey Beran Rose Sells 7,732 Shares of Pulmonx (NASDAQ:LUNG) Stock](https://longbridge.com/en/news/277978473.md)
- [How BBP-418’s Positive Phase 3 FORTIFY Readout At BridgeBio Pharma (BBIO) Has Changed Its Investment Story](https://longbridge.com/en/news/278110534.md)
- [Investment Manager Loads Up on CELC Stock, Adds 135,000 Shares, According to Latest SEC Filing](https://longbridge.com/en/news/278123465.md)